يعرض 8,181 - 8,200 نتائج من 32,444 نتيجة بحث عن '(( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( a step decrease ))', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 8181

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  2. 8182

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  3. 8183

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  4. 8184

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  5. 8185

    table5_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  6. 8186

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf حسب Jordi Rodon (201558)

    منشور في 2021
    "…Four of these families, including novel cathepsin inhibitors, blocked viral entry in a cell—type specific manner. Since the most effective antivirals usually combine therapies that tackle the virus at different steps of infection, we also assessed several drug combinations. …"
  7. 8187
  8. 8188

    Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma حسب Xuejiao Shi (1684186)

    منشور في 2016
    "…It was reported that 5-hmC levels were decreased in a variety of cancers and could be regarded as an epigenetic hallmark of cancer. …"
  9. 8189

    Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts حسب Ansar S. Zhalyalov (4233721)

    منشور في 2017
    "…<div><p>Fibrinolysis is a cascade of proteolytic reactions occurring in blood and soft tissues, which functions to disintegrate fibrin clots when they are no more needed. …"
  10. 8190
  11. 8191
  12. 8192
  13. 8193

    CLP results in long-lasting myeloid inflammation in the brain. حسب Benjamin H. Singer (358781)

    منشور في 2016
    "…The proportion of PMN and monocytes increase at 14 days in post-CLP mice, however, while decreasing in sham operated controls. By 50 days after CLP, the proportion of PMN and monocytes decreases nearly to baseline.…"
  14. 8194

    <i>atoh1a</i> is required for the specification of the <i>lhx2b</i> neuronal population. حسب Ivan Belzunce (8394237)

    منشور في 2020
    "…Note that <i>atoh1b</i> expression (compare A-A’ and G-G’ with D-D’ and J-J’), and the lateral domains of <i>lhx2b</i> diminished (compare white asterisks in B-B’ with E-E’, and H-H’ with K-K’), whereas the more medial domain does not decrease so dramatically (compare white arrowheads in B-B’ with E-E’, and H-H’ with K-K’). …"
  15. 8195

    Optical Control of Insect Behavior and Receptors with Azobenzene-Bridged Fipronil and Imidacloprid حسب Wen Fu (2040040)

    منشور في 2024
    "…IMI-AB-FIP in both <i>trans</i>/<i>cis</i> isomers can be reversibly interconverted depending on light, accompanied by insecticidal activity decrease or increase by 1.5–2.3 folds. In addition, IMI-AB-FIP displayed synergistic effects against A. craccivora (LC<sub>50, IMI‑AB‑FIP</sub> = 14.84–22.10 μM, LC<sub>50, IMI‑AB‑IMI</sub> = 210.52–266.63 μM, LC<sub>50, and FIP‑AB‑FIP</sub> = 36.25–51.04 μM), mainly resulting from a conceivable reason for simultaneous targeting on both GABARs and nAChRs. …"
  16. 8196
  17. 8197
  18. 8198
  19. 8199

    Simultaneous Measurement of Glass-Transition Temperature and Crystallinity of As-Prepared Polymeric Films from Restitution حسب Jinwon Park (5539865)

    منشور في 2021
    "…Demonstrating with eight different types of polymers, we show that <i>T</i><sub>g</sub> is the onset of the decrease in restitution, and <i>X</i><sub>c</sub> is the minimum restitution for semi-crystalline polymers with <i>X</i><sub>c</sub> up to 50%. …"
  20. 8200

    Simultaneous Measurement of Glass-Transition Temperature and Crystallinity of As-Prepared Polymeric Films from Restitution حسب Jinwon Park (5539865)

    منشور في 2021
    "…Demonstrating with eight different types of polymers, we show that <i>T</i><sub>g</sub> is the onset of the decrease in restitution, and <i>X</i><sub>c</sub> is the minimum restitution for semi-crystalline polymers with <i>X</i><sub>c</sub> up to 50%. …"